(Q46824216)

25 December 2017

title

Effects of highly active antiretroviral therapy on paediatric metabolite levels (English)

1 reference

25 December 2017

author

Caroline Sabin

6

1 reference

25 December 2017

author name string

Rhoads MP

1

1 reference

25 December 2017

Smith CJ

2

1 reference

25 December 2017

Tudor-Williams G

3

1 reference

25 December 2017

Kyd P

4

1 reference

25 December 2017

Walters S

5

1 reference

25 December 2017

Lyall EG

7

1 reference

25 December 2017

publication date

1 January 2006

1 reference

25 December 2017

published in

HIV Medicine

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

16-24

1 reference

25 December 2017

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Lipodystrophy syndrome in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Lactate levels in children with HIV/AIDS on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Calibration of the paediatric index of mortality in UK paediatric intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

PENTA guidelines for the use of antiretroviral therapy, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

Lipid profiles associated with antiretroviral drug choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00337.X

10.1111/J.1468-1293.2005.00337.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017